FDA 510(k) FDA class 1 Substantially Equivalent 🇺🇸 United States

MYCOPLASMA PNEUMONIAE ANTIBODY EIA TEST SYSTEM

K Number: K920212 · Decision Aug 20, 1992
Classifications
1
FEI Numbers
14
Registration Numbers
14
Same Product Code
12
Applicant Total
5
Review Days
217

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
MYCOPLASMA PNEUMONIAE ANTIBODY EIA TEST SYSTEM
K Number
K920212
Device Class
FDA class 1
Clearance Type
Traditional
Regulation Number
866.3375
Medical Specialty
Microbiology
Decision
Substantially Equivalent
Statement or Summary
Statement
Applicant
Shared Systems, Inc.
Date Received
January 16, 1992
Decision Date
August 20, 1992
Product Code
LJZ
Advisory Committee
Microbiology
Review Advisory Committee
MI
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LJZ Enzyme Linked Immunoabsorbent Assay, Mycoplasma Spp.

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (LJZ), ordered by most recent decision date.

View all

Other Clearances by Shared Systems, Inc.

K Number Device Name
K973457 CHROMALEX E. COLI 0157 LATEX TEST SYSTEM, PROD. NO. 800
K955042 CHROMALEX C-REACTIVE PROTEIN LATEX TEST SYSTEM
K950073 MYCOPLASMA PNEUMONIAE ANTIBODY LATEX AGGLUTINATION TEST SYSTEM
K953261 CHROMALEX RHEUMATOID FACTOR LATEX TEST SYSTEM